| First Author | Xiang M | Year | 2023 |
| Journal | iScience | Volume | 26 |
| Issue | 4 | Pages | 106561 |
| PubMed ID | 37123234 | Mgi Jnum | J:335732 |
| Mgi Id | MGI:7470437 | Doi | 10.1016/j.isci.2023.106561 |
| Citation | Xiang M, et al. (2023) Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice. iScience 26(4):106561 |
| abstractText | Aquaporin-8(AQP8), is a transmembrane channel protein that abounds in liver, which mainly promotes water transport, modulating bile acid formation. However, its role in hepatic lipid metabolism remains unclear. In this study, we found the expression of AQP8 was reduced in liver specimens of patients with NAFLD, high-fat diet (HFD)-induced mice and genetically obese db/db mice. Knockdown of AQP8 in hepatocytes exacerbated the intracellular lipid accumulation induced by free fatty acid (FFA) mixtures. In contrast, hepatic AQP8 overexpression activated farnesoid X receptor (FXR), inhibiting gene expression associated with lipogenesis, which further reduced intrahepatic triglyceride overload in obese mice. FXR knockout abrogated the ameliorating effect of AQP8 overexpression on NAFLD in mice. These findings indicate that AQP8 overexpression protects against fatty liver through activating the FXR pathway. |
